White label ELPA - ClinicalTrials.eu

Study on the Long-Term Safety of Glepaglutide for Adults with Short Bowel Syndrome

Not recruiting

3 1 1
Investigated Diseases:
- Short-bowel syndrome
Investigated Drugs:
- Glepaglutide
Study on the Effect of Allopurinol and Hypothermia for Newborns with Hypoxic-Ischemic Encephalopathy

Not recruiting

3 1 1
Investigated Diseases:
- Encephalopathy neonatal
- Neonatal asphyxia
Investigated Drugs:
- Allopurinol Sodium
- Mannitol
+3
Study of QEL-001 (CAR T regulatory cell therapy) to prevent liver transplant rejection in patients with HLA-A2 positive donor organ

Not recruiting

2 1 1
Investigated Diseases:
- Liver transplant rejection
Investigated Drugs:
- Autologous T Regulatory Cells Expressing An Hla-A2-Specific Chimeric Antigen Receptor
Study on Bezafibrate for Patients with Primary Sclerosing Cholangitis and Persistent Cholestasis Despite Ursodeoxycholic Acid Therapy

Not recruiting

3 1 1
Investigated Drugs:
- Bezafibrate
Study on Hormonal Treatment with Leuprorelin Acetate for Prostate Cancer Patients at High Risk of Recurrence After Surgery

Not recruiting

3 1 1 1
Investigated Diseases:
- Prostate cancer
Investigated Drugs:
- Leuprorelin Acetate
Study Comparing Rituximab with Drug Combination for Patients with Newly Diagnosed High-Risk Burkitt Lymphoma

Not recruiting

3 1 1 1
Investigated Drugs:
Study on Amantadine and Transcranial Magnetic Stimulation for Reducing Fatigue in Multiple Sclerosis Patients

Not recruiting

3 1 1 1
Investigated Diseases:
- Multiple sclerosis
Investigated Drugs:
- Amantadine Hydrochloride
Study on Elafibranor for Patients with Primary Biliary Cholangitis Not Responding to Ursodeoxycholic Acid

Not recruiting

4 1
Investigated Diseases:
- Primary biliary cholangitis
Investigated Drugs:
- Elafibranor
Study of Trientine Dihydrochloride (Cufence) to Evaluate Its Effects and Safety in Patients with Wilson’s Disease

Not recruiting

3 1 1 1
Investigated Diseases:
- Hepato-lenticular degeneration
Investigated Drugs:
- Trientine Dihydrochloride
Study of FNP-223 tablets to slow disease progression in patients with Progressive Supranuclear Palsy (PSP)

Not recruiting

2 1
Investigated Diseases:
- Progressive supranuclear palsy
Investigated Drugs:
- (S)-N-(5-(4-(1-(Benzo[D][1,3]Dioxol-5-Yl)Ethyl)Piperazin-1-Yl)-1,3,4-Thiadiazol-2-Yl)Acetamide, Hydrochloride Salt
+1

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies